Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL

Neurobiology of Aging

Volumn 21, Issue 4, 2000, Pages 511-524

  Anderson, Aileen J ^a   Stoltzner, Sarah ^a   Lai, Florence ^b   Su, Joseph ^a   Nixon, Ralph A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Apoptosis; Cell death; DNA damage; High molecular weight DNA fragmentation; Necrosis; Neurodegeneration; Postmortem tissue archival; TUNEL

Indexed keywords

DNA FRAGMENT; FORMALDEHYDE;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRUCTURE; DOWN SYNDROME; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; MALE; NERVE DEGENERATION; NEUROPATHOLOGY; NICK END LABELING; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOPTOSIS; DNA; DNA DAMAGE; DNA FRAGMENTATION; DOWN SYNDROME; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NECROSIS; SEX FACTORS; TISSUE BANKS;

EID: 0034622238     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00126-3     Document Type: Article

References (68)

1. Anderson AJ, Ruehl W, Fleishmann L, Stenstrom K, Entriken T, Cummings BJ. DNA damage and apoptosis in the aged canine brain: relationship to Aβ deposition in the absence of neuritic pathology. Prog Neuropsychopharm Behav Psych, In Press.
2. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease co-localization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay . J Neurosci. 16:1996;1710-1719.
3. Ankarcrona M., Dypbutk J.M., Bonfoco E., Zhivotovshy B., Nicotera P. , Glutamate-induced neuronal death a succession of necrosis or apoptosis depending on mitochondrial function . Neuron. 15:1995;961-973.
4. Aylward E.H., Li Q., Honeycutt N.A., et al. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am J Psychiatry. 156:1999;564-568.
5. Boultwood J., Kaklamanis L., Gatter K.C., Wainscoat J.S. Pulsed field gel electrophoresis on frozen tumor tissue sections. J Clin Pathol. 45:1992;722-723.
6. Brown D.G., Sun X., Cohen G.M. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments before internucleosomal fragmentation. J Biol Chem. 268:1993;3037-3039.
7. Busciglio J., Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
8. Cebers G., Zhivotovsky B., Ankarcrona M., Liljequist S. AMPA neurotoxicity in cultured cerebellar granule neurons mode of cell death . Brain Res Bull. 43:1997;393-403.
9. Ceccatelli S., Ahlbom E., Diana A., Zhivotovsky B. Apoptosis in rat hippocampal dentate gyrus after intraventricular colchicine. Neuroreport. 8:1997;3779-3783.
10. Chang E., Luna J., Giacalone J., Uyar D., Silverman G.A., Francke U. Regional localization of 56 new human chromosome 18-specific yeast artificial chromosomes. Cytogenet Cell Genet. 65:1994;136-139.
11. Cummings B., Head E., Afagh A., Milgram N.W., Cotman C. β-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learning Memory. 66:1996;11-23.
12. Cummings B., Head E., Ruehl W., Milgram N., Cotman C. The canine as an animal model of human aging and dementia. Neurobiol Aging. 17:1996;259-268.
13. Cummings B.J., Su J.H., Cotman C.W., White R., Russell M.J. β-amyloid accumulation in aged canine brain a model of early plaque formation in Alzheimer's disease . Neurobiol Aging. 14:1993;547-560.
14. Dong Z., Saikumar P., Weinberg J.M., Venkatachalam M.A. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol. 151:1997;1205-1213.
15. Dragunow M., Faull R.L., Lawlor P., et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport. 6:1995;1053-1057.
16. Fujikawa D.G., Shinmei S.S., Cai B. Lithium-pilocarpine-induced status epilepticus produces necrotic neurons with internucleosomal DNA fragmentation in adult rats. Eur J Neurosci. 11:1999;1605-1614.
17. Gavrieli Y., Sherman Y., Ben S.S. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
18. Gomez-Isla T., Hollister R., West H., et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 41:1997;17-24.
19. Gomez-Isla T., Price J.L., McKeel D.W. Jr, Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 16:(14):1996;4491-4500.
20. Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1993;1945-1951.
21. Guo Q., Fu W., Xie J., et al. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nature Med. 4:1998;957-962.
22. Gwag B.J., Canzoniero L.M., Sensi S.L., et al. Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons. Neuroscience. 90:1999;1339-1348.
23. Head E, Callahan H, Muggenburg BA, Cotman CW, Milgram NW. Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol Aging, 1998;19:415-25.
24. Hof P.R., Bouras C., Perl D.P., Sparks D.L., Mehta N., Morrison J.H. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol. 52:1995;379-391.
25. Hosoda R., Saido T.C., Otvos L. Jr, et al. Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brains. Journal of Neuropathology and Experimental Neurology. 57:(11):1998;1089-1095.
26. Iwatsubo T., Mann D.A., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (Aβ) deposition. Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol. 37:1995;294-299.
27. Jesionek-Kupnicka D., Buczynski J., Kordek R., et al. Programmed cell death (apoptosis) in Alzheimer's disease and Creutzfeldt-Jakob disease. Folia Neuropathologica. 35:1997;233-235.
28. Katoaka A., Kubota M., Wakazono Y., et al. Association of high molecular weight DNA fragmentation with apoptotic or non-apoptotic cell death induced by calcium ionophore. FEBS Lett. 364:1995;264-267.
29. Kiatipattanasakul W., Nakamura S., Hossain M.M., et al. Apoptosis in the aged dog brain. Acta Neuropathol (Berl). 92:1996;242-248.
30. Kingsbury A.E., Mardsen C.D., Foster O.J. DNA fragmentation in human substantia nigra apoptosis or perimortem effect? Movement Disorders. 13:1998;877-884.
31. Kockx M.M., Muhring J., Knaapen M.W., de Meyer G.R. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 152:1998;885-888.
32. Lai F. Clinicopathologic features of Alzheimer disease in Down syndrome. Prog Clin Biol Res. 379:1992;15-34.
33. Lai F., Williams R.S. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 46:1989;849-853.
34. Lassmann H., Bancher C., Breitschopf H., et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
35. Lemere C.A., Blusztajn J.K., Yamaguchi H., Wisniewski T., Saido T.C., Selkoe D.J. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome implications for initial events in amyloid plaque formation . Neurobiol Disease. 3:1996;16-32.
36. Leverenz J.B., Raskind M.A. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients a regional quantitative analysis . Exp Neurol. 150:1998;296-304.
37. Li WP, YCW, Lai HW, Yew DT. Terminal dUTP nick-end labeling (TUNEL) positive cells in the difference regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci 1997;8:75-82.
38. Lippa C.F., Hamos J.E., Pulaski S.D., DeGennaro L.J., Drachman D.A. Alzheimer's disease and aging effects on perforant pathway perikarya and synapses . Neurobiol Aging. 13:1992;405-411.
39. Lucassen P.J., Chung W.J.C., Kamphorst W., Swaab D.F. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol. 56:1997;887-900.
40. MacManus J.P., Rasquinha I., Tuor U., Preston E. Detection of higher-order 50- and 10-kbp DNA fragments before apoptotic internucleosomal cleavage after transient cerebral ischemia. J Cereb Blood Flow Metab. 17:1997;376-387.
41. Mann D.A. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev. 43:1988;99-136.
42. Mirra S.S., Heyman A., McKeel D., et al. The consortium to establish a registry for Alzheimer's disease (CERAD) part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurol. 41:1991;479-486.
43. Motte J., Williams R.S. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol (Berl). 77:1989;535-546.
44. Noetzel M.J. Dementia in Down Syndrome. Morris JC, Morris JCs, editors. 1994;243-264 Marcel-Dekker, Handbook of dementing illnesses. New York.
45. Oberhammer F., Wilson J.W., Dive C., et al. Apoptotic death in epithelial cells cleavage of DNA to 300 and or 50kb fragments before or in the absence of internucleosomal fragmentation . EMBO J. 12:1993;3679-3684.
46. Oliver C., Crayton L., Holland A., Hall S., Bradbury J. A 4 year prospective study of age-related cognitive change in adults with Down's syndrome. Psychol Med. 28:1998;1365-1377.
47. Perry G., Nunomura A. Apoptosis and Alzheimer's disease. Science. 282:1998;1268.
48. Perry G., Nunomura A., Smith M.A. A suicide note from Alzheimer disease neurons? Nature Medicine. 4:1998;897-898.
49. Portera-Cailliau C., Herdeen J.C., Price D.L., Koliatsos V.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci. 15:1995;3775-3787.
50. Portera-Cailliau C., Price D.L., Martin L.J. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct further evidence for an apoptosis-necrosis continuum . J Comp Neurol. 378:1997;88-104.
51. Prasher V.P., Farrer M.J., Kessling A.M., et al. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol. 43:1998;380-383.
52. Ross M.H., Galaburda A.M., Kemper T.L. Down's syndrome is there a decreased population of neurons? Neurology. 34:1984;909-916.
53. Roychoudhury R., Wu R. Terminal transferase-catalyzed addition of nucleotides to the 3′ termini of DNA. Methods in Enzymology. 65:(1):1980;43-62.
54. Ruiz R.M., Oliver F.J., Izquierdo M., Lopez R.A. Activation-induced apoptosis in Jurkat cells through a myc-independent mechanism. Mol Immunol. 32:(13):1995;947-955.
55. Rumble B., Retallack R., Hilbich C., et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease [see comments]. N Engl J Med. 320:1989;1446-1452.
56. Schapiro M.B., Haxby J.V., Grady C.L. Nature of mental retardation and dementia in Down syndrome study with PET, CT and neuropsychology . Neurobiol Aging. 13:1992;723-734.
57. Sheng J.G., Mrak R.E., Griffin W.S. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease. J Neuropathol Exp Neurol. 57:1998;323-328.
58. Smale G., Nichols N.R., Brady D.R., Finch C.E., Horton W.J. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol. 133:1995;225-230.
59. Sohn S., Kim E.Y., Gwag B.J. Glutamate neurotoxicity in mouse cortical neurons atypical necrosis with DNA ladders and chromatin condensation . Neurosci Lett. 240:1998;147-150.
60. Stadelmann C., Bruck W., Bancher C., Jellinger K., Lassman H. Alzheimer disease. DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol. 57:1998;456-464.
61. Su J.H., Anderson A.J., Cummings B.J., Cotman C.W. Immunohistochemical evidence for DNA fragmentation in neurons in the AD brain. Neuroreport. 5:1994;2529-2533.
62. Su J.H., Deng G., Cotman C.W. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res. 774:1997;193-199.
63. Teller J.K., Russo C., DeBusk L.M., et al. Presence of soluble amyloid β-protein precedes amyloid plaque formation in Down's syndrome. Nature Med. 2:1996;93-95.
64. Troncoso J.C., Sukhov R.R., Kawas C.H., Koliatsos V.E. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease correlations with senile plaques and disease progression . J Neuropathol and Exp Neurol. 55:1996;1134-1142.
65. Walker P.R., Kokileva L., LeBlanc J., Sikorska M. Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques. 15:1993;1032-1040.
66. Walker P.R., Weaver V.M., Lach B., LeBlanc J., Sikorska M. Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp Cell Res. 213:1994;100-106.
67. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 344:1994;769-772.
68. Yang F., Sun X., Beech W., et al. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease [see comments]. Am J Pathol. 152:1998;379-389.